Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinne Blachier-Poisson

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Therapie|April 16, 2016
"Big data" and "open data": What kind of access should researchers enjoy?Gilles Chatellier, Vincent Varlet, Corinne Blachier-Poisson, et al.
Therapie|July 10, 2016
[Not Available]Danièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|February 14, 2015
Biosimilars: from technical to pharmacoeconomic considerations. 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé. Tables rondesDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|July 10, 2016
Biosimilars: from Technical to Pharmacoeconomic ConsiderationsDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Therapie|April 16, 2016
"Big data" and "open data": What kind of access should researchers enjoy?Gilles Chatellier, Vincent Varlet, Corinne Blachier-Poisson, et al.
Therapie|July 10, 2016
[Not Available]Danièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|February 14, 2015
Biosimilars: from technical to pharmacoeconomic considerations. 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé. Tables rondesDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|July 10, 2016
Biosimilars: from Technical to Pharmacoeconomic ConsiderationsDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Pageof 1